SINUS TARSI SYNDROME

SINUS TARSI SYNDROME was reported 28 times

SINUS TARSI SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Barbiturate [EPC] 1 0.0001
1 Estrogen Receptor Antagonist [EPC] 2 0.0000
2 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
3 Arteriolar Vasodilator [EPC] 2 0.0000
4 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
5 Fluoroquinolone Antibacterial [EPC] 3 0.0000
6 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
7 Estrogen [EPC] 4 0.0000
8 Ester Local Anesthetic [EPC] 1 0.0000
9 Aminosalicylate [EPC] 2 0.0000
10 Vitamin D [EPC] 6 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
12 Complement Inhibitor [EPC] 1 0.0000
13 Aromatase Inhibitor [EPC] 2 0.0000
14 Methylxanthine [EPC] 1 0.0000
15 Glycopeptide Antibacterial [EPC] 1 0.0000
16 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
17 Leukocyte Growth Factor [EPC] 2 0.0000
18 Calcium [EPC] 2 0.0000
19 Non-Standardized Chemical Allergen [EPC] 1 0.0000
20 Amide Local Anesthetic [EPC] 1 0.0000
21 Central Nervous System Stimulant [EPC] 1 0.0000
22 Antiarrhythmic [EPC] 1 0.0000
23 Expectorant [EPC] 2 0.0000
24 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
25 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
27 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
29 Vitamin C [EPC] 3 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
31 Platelet Aggregation Inhibitor [EPC] 3 0.0000
32 Interferon beta [EPC] 1 0.0000
33 Proton Pump Inhibitor [EPC] 3 0.0000
34 Thiazide Diuretic [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
36 GLP-1 Receptor Agonist [EPC] 2 0.0000
37 Progestin [EPC] 1 0.0000
38 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
39 Vitamin B12 [EPC] 1 0.0000
40 Insulin Analog [EPC] 1 0.0000
41 Benzodiazepine [EPC] 1 0.0000